Cerenome, Inc. (CNSY)
Snapshot
- 1 week
- +3.7%+4.2% vs SPY
- 1 month
- -9.1%-8.2% vs SPY
- Market cap
- $11.7M
- P/E
- negindustry 58.3
- P/B
- 2.1
- EV/EBITDA
- -0.5
- Short % float
- 11.5%
- Days to cover
- 3.5
- Short change
- +4.4%
- Consensus
- Buy2 buy · 0 hold · 0 sell
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Cerenome, Inc. (CNSY). Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
- Marc H. HedrickPresident, CEO & DirectorUSD 934K
- Andrew J. SimsVP & CFOUSD 557K
- Eric J. DanielsChief Development Officer
- Russell W. BradleyPresident & GM of CNSide Diagnostics, LLC
- Russ HavranekExecutive Vice President of Commercial and Corporate Strategy
- Desiree SmithCorporate Controller
Snapshot
Price & returns1 month -9.1%
- 1 week
- +3.7%+4.2% vs SPY
- 1 month
- -9.1%-8.2% vs SPY
ValuationP/E neg vs industry 58.3 · market cap $11.7M
- Market cap
- $11.7M
- P/E
- negindustry 58.3
- P/B
- 2.1
- EV/EBITDA
- -0.5
Short interest & optionsshort 11.5% of float
- Short % float
- 11.5%
- Days to cover
- 3.5
- Short change
- +4.4%
Street & earnings2 buy · 0 hold · 0 sell2 buy · 0 hold · 0 sell
- Consensus
- Buy2 buy · 0 hold · 0 sell
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Cerenome, Inc. (CNSY). Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
- Marc H. HedrickPresident, CEO & DirectorUSD 934K
- Andrew J. SimsVP & CFOUSD 557K
- Eric J. DanielsChief Development Officer
- Russell W. BradleyPresident & GM of CNSide Diagnostics, LLC
Company news
Congress trades
STOCK Act filings